Latest filing published 07 Aug 2026 for OKYO Pharma Ltd, €20k.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Robert John Dempsey appears in our data through filings on OKYO Pharma Ltd shares, published by SEC (Form 4). In total, 2 filings cover trades dated 22 July 2026.
The open-market record is one-sided, with 1 purchase worth €20k and not one sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 1 share grant.
The latest filing, published on 7 August 2026, reports an open-market purchase of €20k in OKYO Pharma Ltd. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations